Latest / Viewpoint Alabama / Peptides & Meta
Transcript
- 0:02Speaker 1: It sounds almost like science fiction, although there's some real
- 0:06Speaker 1: science fact here. And I'm talking about these GLP-1s, these
- 0:10Speaker 1: what are otherwise known as peptides in the scientific community.
- 0:14Speaker 1: And there's a lot more to be known than just
- 0:16Speaker 1: weight loss. This is Viewpoint Alabama on the Alabama Radio Network.
- 0:20Speaker 1: I'm John Mountain. I'm joined today by Dr. Joe Gulati.
- 0:24Speaker 1: Good morning, Dr.
- 0:24Speaker 2: Joe.
- 0:25Speaker 3: Hey, it's always great to be with you and really
- 0:27Speaker 3: shed a little bit of light on a very, very
- 0:29Speaker 3: hot topic in healthcare.
- 0:31Speaker 1: A lot of people are talking about this because, as
- 0:33Speaker 1: I understand, with these peptides, these GLP-1s, it started off
- 0:36Speaker 1: as a drug just to help with, I guess it
- 0:39Speaker 1: was diabetes, right? And they found out a happy side
- 0:41Speaker 1: effect was the weight loss.
- 0:43Speaker 3: Right. Well, what happens is that is one of many,
- 0:47Speaker 3: many peptides that are available. And so where we've become
- 0:50Speaker 3: familiar with the ozempics of the world, which is a
- 0:54Speaker 3: glucagon peptide, but there are many other peptides that are
- 1:00Speaker 3: being used and they are touted to help or reduce
- 1:06Speaker 3: all kinds of various health maladies that we have, everything
- 1:10Speaker 3: from longevity to better skin, better neurologic function.
- 1:14Speaker 4: And the one area that is receiving a lot of
- 1:17Speaker 4: attention is healing.
- 1:19Speaker 3: If you go for surgery or if you have an
- 1:22Speaker 3: injury that your muscles, your tendons, your fibers are.
- 1:26Speaker 4: Going to grow back faster.
- 1:27Speaker 3: Now, that all sounds great and I am all in
- 1:30Speaker 3: favor of the science and learning about this, but The
- 1:33Speaker 3: biggest take home here is that the basic science, the
- 1:38Speaker 3: research that's being done literally in rats has no proven
- 1:43Speaker 3: human results. The data in the research is lacking in
- 1:48Speaker 3: all of these other peptides that are being touted. And
- 1:53Speaker 3: that is where things.
- 1:54Speaker 4: Get a little crazy because.
- 1:56Speaker 3: There are compounds out there that we don't know fully
- 2:01Speaker 3: how they work in the body. We don't know the safety.
- 2:05Speaker 3: They're not FDA regulated at this point. There's a gray
- 2:08Speaker 3: market source of these compounds that go into the drug.
- 2:13Speaker 3: And so it is just sort of this mysterious black
- 2:16Speaker 3: hole to say, hey, here's a peptide. If you went
- 2:19Speaker 3: for surgery, it's going to make you rebound a lot faster.
- 2:22Speaker 3: It's going to make your skin look good. Your stomach
- 2:25Speaker 3: is going to function better. But we just don't.
- 2:27Speaker 4: Have the research. And that's the tough part.
- 2:30Speaker 3: As consumers, we want to get these answers. We want
- 2:34Speaker 3: the shortcuts. We want the biohacks. But the truth is
- 2:37Speaker 3: the research is lacking.
- 2:39Speaker 1: And the thing is, nobody wants to be a guinea pig.
- 2:41Speaker 1: So before we can really try it in people, they
- 2:44Speaker 1: got to try it on animals. And sometimes that animal
- 2:47Speaker 1: model is not the same. So how do we jump
- 2:49Speaker 1: from just a theory to actually getting it done?
- 2:54Speaker 3: Well, I mean, this is where the whole scientific process,
- 2:57Speaker 3: and there's a lot of people that are just simply impatient,
- 3:00Speaker 3: that there are these compounds that are slowly being tested
- 3:04Speaker 3: in humans, and it's going to take time. But you know,
- 3:08Speaker 3: everybody wants to know, well, how do I know? They
- 3:10Speaker 3: are available commercially. You could get them online. You could
- 3:13Speaker 3: just do a Google search for peptides. And there are
- 3:16Speaker 3: probably 50 to 100 websites where you could just put
- 3:18Speaker 3: a credit card down and you'll have these injectable peptides delivered,
- 3:22Speaker 3: you know, in 24 hours. But I would think that
- 3:24Speaker 3: you have to see where are they coming from? Are
- 3:28Speaker 3: they being, you know, prescribed or supervised by a physician?
- 3:33Speaker 3: If you are taking these, are you going for follow-up
- 3:37Speaker 3: blood work? Are you going up for a follow-up clinical exam?
- 3:41Speaker 3: Or are you just going to take these until you
- 3:44Speaker 3: feel like you don't want to take them anymore and
- 3:46Speaker 3: miss out on potential side effects? That really is my
- 3:51Speaker 3: major concern. I do think that there is merit to
- 3:54Speaker 3: some of these, but without the testing, I'm really, in
- 3:58Speaker 3: a sense, forced to signal caution for everybody.
- 4:03Speaker 1: And a peptide is not a controlled substance, but at
- 4:07Speaker 1: the same time, there are recommended ways to take these things,
- 4:12Speaker 1: to not take these things. I mean, you can inject it.
- 4:15Speaker 1: You can ingest it. It can be topical. All different
- 4:18Speaker 1: ways you can apply a medication. People don't understand how
- 4:23Speaker 1: to dose it, how to apply it, all those kinds
- 4:25Speaker 1: of things. And I'm afraid people might just try to
- 4:29Speaker 1: self-medicate and then possibly do damage.
- 4:31Speaker 5: Right.
- 4:32Speaker 4: Well, exactly.
- 4:34Speaker 3: And again, when you're getting these sort of gray market
- 4:38Speaker 3: components of these peptides and you don't know the purity,
- 4:42Speaker 3: they are not being manufactured specifically for human consumption. And
- 4:48Speaker 3: there are multiple loopholes here that are allowing this to happen.
- 4:50Speaker 3: There are these components of the peptides that are clearly,
- 4:56Speaker 3: clearly labeled for research only, to be used in animals,
- 5:01Speaker 3: not to be used in humans. And so part of
- 5:04Speaker 3: the process of testing a new medication is what is
- 5:07Speaker 3: a dose of a particular drug that works? What is
- 5:11Speaker 3: a drug that is toxic? Where do you start seeing
- 5:13Speaker 3: side effects? And you find the sweet spot. But if
- 5:16Speaker 3: these are unregulated, you just don't know what you're getting.
- 5:22Speaker 3: And that is where we would just say, buyer, beware.
- 5:25Speaker 3: You have to be a good consumer to make sure
- 5:28Speaker 3: that you don't do more harm than benefit.
- 5:31Speaker 1: This is Viewpoint Alabama on the Alabama Radio Network. My
- 5:34Speaker 1: name is John Mounce. I'm speaking with Dr. Joe Galati
- 5:36Speaker 1: about peptides. And Dr. Joe, there are pharmacies now that
- 5:41Speaker 1: do what they call compounding, where they sort of put
- 5:44Speaker 1: things together for you. And I know some of them
- 5:46Speaker 1: are dealing in peptides. Is that safer than trying to
- 5:50Speaker 1: put it together yourself? Or still, you should kind of
- 5:52Speaker 1: view that with caution.
- 5:53Speaker 4: I think you have to view it with caution.
- 5:57Speaker 3: As far as I know, this is not a do-it-yourself
- 6:00Speaker 3: sort of thing where you mix it on your kitchen table.
- 6:04Speaker 3: But here again, the pharmacy, the compounding pharmacy, is going
- 6:08Speaker 3: to get various components, various ingredients that they're going to
- 6:14Speaker 3: mix together. And you don't know the quality, the purity
- 6:19Speaker 3: of the different ingredients. elements that you're putting together into
- 6:22Speaker 3: that final product. So just because it's coming from a
- 6:26Speaker 3: compounding pharmacy does not guarantee Now, again, I think it's
- 6:32Speaker 3: going to take a lot of work on the part
- 6:34Speaker 3: of the consumer to verify the confidence that you have
- 6:42Speaker 3: in a pharmacy. Is it a place where you walk
- 6:45Speaker 3: into or is it something strictly online? And again, is
- 6:49Speaker 3: there a physician or other health care provider that's navigating
- 6:53Speaker 3: you through this process.
- 6:55Speaker 4: So again, there.
- 6:57Speaker 3: Are enough loopholes in the system to get these various
- 7:02Speaker 3: compounding pharmacies to make these. There's various loopholes to get
- 7:07Speaker 3: these gray products, gray market products in from around the world.
- 7:12Speaker 3: A lot of these are coming from China. And so
- 7:16Speaker 3: on the surface, you could say, hey, this is legitimate.
- 7:19Speaker 3: But at the end of the day, when you put
- 7:21Speaker 3: it all together and test it, There is woefully, woefully.
- 7:25Speaker 4: A lack of human data to show that it works.
- 7:28Speaker 3: And again, anecdotally, you know, there are going to be
- 7:32Speaker 3: influencers online, websites that are going to say, hey, we
- 7:34Speaker 3: had 10 or 15 patients.
- 7:36Speaker 4: We put them on a peptide. They got back to work.
- 7:39Speaker 3: They were exercising better, et cetera, et cetera. But that's
- 7:44Speaker 3: anecdotal really has no scientific value in it.
- 7:47Speaker 1: And another thing I'm concerned about is even if you're
- 7:50Speaker 1: able to obtain drugs that you know are put together
- 7:54Speaker 1: correctly from the pharmacy, most of these are administered, I believe,
- 7:58Speaker 1: through injection. And it's not really safe for people to,
- 8:03Speaker 1: unless you have a really good sterile environment, for you
- 8:05Speaker 1: to just be mixing up your own stuff, putting it
- 8:07Speaker 1: in a syringe, putting a needle on it and sticking
- 8:09Speaker 1: it in your arm. That's a good way to get
- 8:11Speaker 1: a pretty serious infection, isn't it?
- 8:13Speaker 3: Well, infection and all other kinds of complications. And I think, John,
- 8:19Speaker 3: what it is is as consumers, the population, we're getting older,
- 8:25Speaker 3: we're having more aches and pains, we don't have that
- 8:28Speaker 3: vitality that we did when we were 30 or 40
- 8:30Speaker 3: years old. And many will do anything, anything possible to
- 8:35Speaker 3: get back to that high level of performance and There
- 8:40Speaker 3: are those that are going to look the other way
- 8:43Speaker 3: and say, you know what? I want to get in
- 8:45Speaker 3: better shape. I want to look better. I want to
- 8:48Speaker 3: feel better, heal faster. And so I'm going to turn
- 8:50Speaker 3: a blind eye to the potential safety concerns or the
- 8:54Speaker 3: lack of research.
- 8:55Speaker 4: And I'm just going to put my head down and
- 8:57Speaker 4: go for it.
- 8:58Speaker 3: That's where I think the online websites and the influencers
- 9:03Speaker 3: take advantage because it is a very, very ripe platform.
- 9:08Speaker 3: population of people that are saying, hey, I'm all in.
- 9:12Speaker 4: I'm going to try this stuff.
- 9:14Speaker 3: And so unless we put up the yellow caution light,
- 9:19Speaker 3: there's going to be plenty of people that are still
- 9:20Speaker 3: going to try these.
- 9:21Speaker 4: And on the other end, I hate to say it,
- 9:24Speaker 4: there's people that are going to make a lot of
- 9:25Speaker 4: money off this.
- 9:26Speaker 1: And when there's money to be made, sometimes caution is
- 9:29Speaker 1: thrown to the wind. Or they just don't care because
- 9:31Speaker 1: they don't have your health in mind. They have the
- 9:33Speaker 1: health of their pocketbook in mind. And so they're happy
- 9:35Speaker 1: to sell you something, even if it's not going to
- 9:37Speaker 1: work or might make you sick.
- 9:39Speaker 4: Absolutely.
- 9:40Speaker 3: And that's a cautionary tale to alert everybody.
- 9:44Speaker 2: Dr.
- 9:44Speaker 1: Joe Gulati, thank you so much for going over some
- 9:46Speaker 1: of these things. Bottom line, I think stick with stuff
- 9:49Speaker 1: that's prescribed for you by your doctor from a reputable source.
- 9:52Speaker 1: Anything else, you know, I would be concerned that something
- 9:56Speaker 1: bad might be on its way.
- 9:58Speaker 3: I would say proceed with caution until we have more data.
- 10:02Speaker 3: And once the research comes out, if it is in
- 10:05Speaker 3: favor of these peptides, I am all in and would
- 10:08Speaker 3: certainly use.
- 10:09Speaker 4: Them in my patients. Dr.
- 10:11Speaker 1: Gulati, thank you so much for joining us today on
- 10:12Speaker 1: Viewpoint Alabama.
- 10:13Speaker 4: Okay, John, thank you.
- 10:15Speaker 1: And up next on Viewpoint Alabama, on the Alabama Radio Network,
- 10:18Speaker 1: there was a landmark decision this past week against Meta.
- 10:22Speaker 1: That's the company that owns Facebook as well as Instagram.
- 10:26Speaker 1: These platforms, it is alleged, were designed to addict children,
- 10:31Speaker 1: much in the same way that nicotine addicts, addict smokers,
- 10:34Speaker 1: and that sort of thing, and in the same way,
- 10:36Speaker 1: There was a lawsuit, and many states' attorneys general joined
- 10:40Speaker 1: in in this lawsuit. Alabama, in particular, is going to
- 10:43Speaker 1: receive $ 117 million from the settlement that the state will
- 10:48Speaker 1: be using. Our own Attorney General Steve Marshall joined JT
- 10:52Speaker 1: to talk about this earlier this week.
- 10:53Speaker 6: Steve, welcome in. Thank you so much for being here.
- 10:55Speaker 2: Good morning, JT.
- 10:57Speaker 7: First of all, congratulations, you and the other attorneys general
- 11:01Speaker 7: that were involved in this.
- 11:02Speaker 6: A high five. Nice job.
- 11:04Speaker 7: You got Alabama $ 117 million out of the $ 17 billion
- 11:09Speaker 7: agreement here. So what were the key factors, and you think,
- 11:13Speaker 7: of Zuckerberg deciding to settle two weeks in as opposed
- 11:16Speaker 7: to this thing potentially going eight weeks long, and he
- 11:18Speaker 7: didn't even have to testify?
- 11:20Speaker 2: Okay.
- 11:21Speaker 4: You know, there's no.
- 11:21Speaker 2: Doubt that they were feeling the pressure. There's a pending
- 11:24Speaker 2: case that was going on in Tennessee. You're seeing another
- 11:27Speaker 2: case was about to start in Colorado. So the pressure
- 11:31Speaker 2: was clearly raising on Meta. And look, we've been in
- 11:34Speaker 2: discussions with them now for multiple years. And JT, we
- 11:38Speaker 2: also have to remember in Alabama, basically a month from now,
- 11:41Speaker 2: we have TikTok going on trial relating to the same
- 11:44Speaker 2: type of claims. And so no doubt that as we
- 11:47Speaker 2: continue to be able to expose what these investigations have revealed,
- 11:51Speaker 2: that social media companies are feeling the pressure, not only
- 11:54Speaker 2: to be able to help with dollar amounts to deal
- 11:57Speaker 2: with issues that they created, but now trying to work
- 12:01Speaker 2: to reform the platform so that it's a better environment
- 12:03Speaker 2: for kids.
- 12:04Speaker 7: So when you talk about the $ 117 million that I
- 12:07Speaker 7: guess is awarded to Alabama, how is that decided by
- 12:10Speaker 7: the courts or who decides what states get what?
- 12:14Speaker 2: Yeah, that's actually the internal allocation was decided among the AGs.
- 12:19Speaker 2: In fact, JT, the 117.
- 12:21Speaker 4: Is the floor.
- 12:22Speaker 2: It could be upwards of $ 200 million by the time
- 12:24Speaker 2: all is said and done. And then the money itself
- 12:28Speaker 2: is ultimately going to be allocated by the legislature. And
- 12:30Speaker 2: so Rex Reynolds, who I think led a charge really
- 12:34Speaker 2: well on the opioid money that we've had coming through now,
- 12:37Speaker 2: is going to have an opportunity through the work of
- 12:40Speaker 2: the legislature to deal with how this money should be
- 12:43Speaker 2: allocated to effectively deal with the issues that impact the kids.
- 12:47Speaker 2: But we're excited about the fact that not only did
- 12:50Speaker 2: we bring those dollars in, but now we've seen structural
- 12:54Speaker 2: changes that are going to come to the platform, whether
- 12:56Speaker 2: it be limits on time for kids, where we now
- 12:59Speaker 2: have more robust determination of age and make sure that
- 13:03Speaker 2: young kids are not getting on when they're not supposed to,
- 13:05Speaker 2: giving parents even greater controls over what's happening with their
- 13:09Speaker 2: kids online, and then making sure that we're not allowing
- 13:14Speaker 2: these platforms to become distractions for kids and learning environments.
- 13:18Speaker 7: Well, when you start to try and get kids to
- 13:20Speaker 7: stick around, and I get it, they're a company, they're
- 13:22Speaker 7: trying to get more people to come to their shop
- 13:23Speaker 7: and spend the money and spend time with them. And
- 13:25Speaker 7: if you get them young, they stay with you longer
- 13:27Speaker 7: and longer and longer. I understand the business model in this,
- 13:30Speaker 7: but you're right. We're talking about kids here. Back up, Zuckerberg.
- 13:34Speaker 7: So he did not admit any wrongdoing or liability in
- 13:37Speaker 7: this case. We should point that out. But he did say,
- 13:39Speaker 7: here's $ 17 billion for you guys. So what does this
- 13:44Speaker 7: mean moving forward as far as TikTok and other platforms?
- 13:47Speaker 7: As Zuckerberg has said, look, now I've done this. The
- 13:49Speaker 7: rest of y'all need to kind of step up and
- 13:51Speaker 7: handle your business too. I understand there may be some
- 13:53Speaker 7: lawsuits in those other directions as well.
- 13:56Speaker 2: Yeah, you know, we've got the TikTok case now for Alabama. Actually,
- 13:59Speaker 2: we have the first in the country case here in
- 14:01Speaker 2: Montgomery at the end of September, and the team's working
- 14:05Speaker 2: really hard to get that ready. You've got pending investigations
- 14:08Speaker 2: going on around YouTube and both Snapchat and And I
- 14:11Speaker 2: do think you're going to see a wholesale change in
- 14:16Speaker 2: a very positive way in all of these social media
- 14:19Speaker 2: platforms that, again, empowers parents, protects kids, and allows for
- 14:25Speaker 2: these particular apps to be used in ways that are
- 14:29Speaker 2: productive and not detrimental to the mental health of children.
- 14:32Speaker 7: Yeah, we were talking earlier about this on the show.
- 14:35Speaker 7: What if, for instance, TikTok decides, you know what, we're
- 14:38Speaker 7: not going to settle. We're going to trial. And then
- 14:40Speaker 7: all of a sudden they win. What does that do
- 14:42Speaker 7: to this settlement?
- 14:43Speaker 3: Nothing?
- 14:44Speaker 2: It doesn't do anything to this settlement. What it does
- 14:46Speaker 2: do is that some of the enhancements that can take
- 14:50Speaker 2: place on the dollar amount have to do with industry
- 14:52Speaker 2: adoption of some of these same changes that Meta is
- 14:56Speaker 2: making to its platform that occur across the industry as
- 14:59Speaker 2: a whole. But, look, if I'm lawyers for TikTok right now,
- 15:02Speaker 2: I'd be pretty doggone scared to be staring in front
- 15:04Speaker 2: of a jury here in a month in Alabama knowing
- 15:07Speaker 2: the fact that we're going to be able to present
- 15:08Speaker 2: and particularly the experts talking about the impact on kids.
- 15:11Speaker 2: All right.
- 15:12Speaker 7: Switching gears, I want to talk to you about AI.
- 15:14Speaker 7: Once again, another technology story that we need to be
- 15:16Speaker 7: concerned about. We were warned early on by Elon Musk,
- 15:19Speaker 7: you better keep an eye on AI. It's going to
- 15:21Speaker 7: get out of control before you know it. Now we've
- 15:23Speaker 7: got Bill Gates saying, look, this is really out of control.
- 15:27Speaker 7: And we've got to do something about this here. And
- 15:28Speaker 7: you guys, I guess, announced an investigation into OpenAI and
- 15:32Speaker 7: CEO Sam Altman there about the cybersecurity because AI apparently
- 15:36Speaker 7: now can go out and develop its own mind and
- 15:39Speaker 7: start doing things without any control.
- 15:41Speaker 6: So what's going on here? What are the nuts and
- 15:43Speaker 6: bolts of this?
- 15:45Speaker 2: Yeah, this is the COVID Wuhan lab just in an
- 15:48Speaker 2: AI environment. I mean, they were testing one of their
- 15:51Speaker 2: models supposedly in a safe environment that was designed to
- 15:55Speaker 2: be able to find and identify weaknesses in the software
- 16:00Speaker 2: and systems of other individuals and companies. And it escapes and,
- 16:05Speaker 2: in fact, goes after another AI platform, penetrates their systems.
- 16:11Speaker 2: And one thing is not only scary do we see
- 16:14Speaker 2: OpenAI not able to control one of their own models,
- 16:17Speaker 2: but even more so, or maybe at least equally concerning,
- 16:21Speaker 2: is that the company that was hacked itself had to
- 16:24Speaker 2: use a Chinese AI model to be able to figure
- 16:28Speaker 2: it out. And JT, this is a scary place. We
- 16:32Speaker 2: have a lot of discussion right now going on around
- 16:34Speaker 2: data centers, and that's appropriate. But we ought to be
- 16:37Speaker 2: talking significantly about AI and where it is this is going.
- 16:41Speaker 2: And you're right, Bill Gates is not somebody that I'm
- 16:44Speaker 2: aligned with very often, but I think he raised some
- 16:47Speaker 2: important points just in a letter yesterday about.
- 16:49Speaker 4: Is this moving too quickly?
- 16:51Speaker 2: Are we able to adequately understand where this is going?
- 16:55Speaker 2: And have we had the opportunity to really assess impact?
- 16:58Speaker 7: Well, you've also got some muscle behind you. Didn't you
- 17:00Speaker 7: get involved with about 14 other state attorneys generals in
- 17:04Speaker 7: demanding this open AI preserve evidence and, you know, keep
- 17:07Speaker 7: an eye on this and we want to see what's
- 17:09Speaker 7: going on. And we've got to protect our folks here
- 17:11Speaker 7: in Alabama and obviously across the country too. I mean,
- 17:14Speaker 7: The consumer protection laws are pretty clear, and this is
- 17:17Speaker 7: stepping into the field of you're starting to violate those.
- 17:20Speaker 4: Absolutely.
- 17:20Speaker 2: I mean, when consumer information is able to be disclosed,
- 17:23Speaker 2: I mean, look, this is simply a hacking operation by
- 17:27Speaker 2: a rogue AI agent that OpenAI couldn't control and kept
- 17:32Speaker 2: it from being able to be unleashed on systems across
- 17:36Speaker 2: the country. And so, yeah, 14 states have banded together
- 17:39Speaker 2: to initially ask OpenAI to preserve their records. We've taken
- 17:43Speaker 2: that next step and said, open an hour, we're going
- 17:45Speaker 2: to investigate.
- 17:47Speaker 7: The big question is, will Arnold Schwarzenegger be a part
- 17:49Speaker 7: of the next movie about all of this madness?
- 17:53Speaker 4: You know, it gets scarier and scarier. It does.
- 17:55Speaker 6: It really does.
- 17:56Speaker 7: But once again, on behalf of everybody here in our state,
- 18:00Speaker 7: and congratulations on the settlement with META and working hard
- 18:04Speaker 7: for this state, $ 117 million, potentially a lot more than
- 18:07Speaker 7: that as well for us here because of this.
- 18:10Speaker 6: I mean, you brought it, and you deserve some high
- 18:13Speaker 6: fives on that.
- 18:13Speaker 4: Nice job. Thank you, JT.
- 18:14Speaker 2: Appreciate it.
- 18:15Speaker 8: You're listening to Viewpoint Alabama, a public affairs program from
- 18:18Speaker 8: the Alabama Radio Network.
- 18:20Speaker 1: Well, here it is fall. The kids are heading back
- 18:22Speaker 1: to school, and we're entrusting the school with their protection.
- 18:26Speaker 1: But there are some things you should know before you
- 18:29Speaker 1: just do that. This is Viewpoint Alabama on the Alabama
- 18:32Speaker 1: Radio Network. My name is John Mounts. Joining me now
- 18:35Speaker 1: is an associate from a law firm, Lever & Ecker.
- 18:38Speaker 1: Her name is Kate Henderson. Kate, welcome to Viewpoint Alabama.
- 18:42Speaker 9: Hi, thank you so much for having me, John.
- 18:44Speaker 1: And when we talk about these programs that your kids
- 18:47Speaker 1: are involved in at school, after school, it's a little
- 18:50Speaker 1: bit different. They don't have a lot of the same safeguards.
- 18:53Speaker 1: There's things that you have to consider when you're just
- 18:56Speaker 1: letting your child be in an after school program, be
- 18:58Speaker 1: it athletics or music or even just the, you know,
- 19:01Speaker 1: like say after school care, right?
- 19:03Speaker 2: That's right.
- 19:04Speaker 9: So, you know, as parents and guardians, we need to
- 19:06Speaker 9: make sure we're doing our due diligence to ensure that
- 19:08Speaker 9: whatever program we're putting our kids into, there's situations where
- 19:12Speaker 9: safety is prioritized.
- 19:14Speaker 1: And I know there's a problem with the people who
- 19:17Speaker 1: are running those programs are not necessarily employed by the school.
- 19:21Speaker 1: They don't necessarily have the same rules about background checks
- 19:24Speaker 1: and that sort of thing. So it's more incumbent on
- 19:26Speaker 1: us to kind of check the program out ahead of time, right?
- 19:28Speaker 3: Yes.
- 19:29Speaker 9: Yeah, absolutely. So, you know, most– I'm located in New York,
- 19:33Speaker 9: and here most public school, after-school programs– fall underneath the
- 19:38Speaker 9: jurisdiction of the Department of Education. However, not all of
- 19:42Speaker 9: them do, especially when it comes to sports programs or
- 19:45Speaker 9: athletic programs that may be off school campus. So it's
- 19:49Speaker 9: really important. that, you know, before you send your kid
- 19:51Speaker 9: up for a program, that you do some investigative work,
- 19:54Speaker 9: that you check with the Department of Education, you check
- 19:56Speaker 9: with the Department of Health to see what requirements are
- 20:00Speaker 9: necessary for the program that you intend to send your
- 20:02Speaker 9: child to.
- 20:04Speaker 1: Another thing is a lot of them, they do contract out,
- 20:06Speaker 1: like say they use something like the YMCA or something
- 20:09Speaker 1: like that, and they might have different standards. So it's
- 20:12Speaker 1: important to check with those organizations to see exactly what
- 20:15Speaker 1: their standards are when they are looking for people and
- 20:18Speaker 1: what their rules are about the children being alone and
- 20:21Speaker 1: what are the child to staff ratios, all those sort
- 20:23Speaker 1: of things.
- 20:24Speaker 3: Yes.
- 20:24Speaker 9: Yeah, absolutely. Most, you know, most programs are required to
- 20:27Speaker 9: be licensed. And if they are, then you have to
- 20:30Speaker 9: see their operating permit. If they claim that they're exempt,
- 20:34Speaker 9: you have to ask them what internal safety standards they
- 20:37Speaker 9: operate under, what their staff student ratios are, and, you know,
- 20:42Speaker 9: whether that changes as it should in the event of
- 20:45Speaker 9: higher risk activities like sports events or swimming and things
- 20:49Speaker 9: like that. You have to be prepared with these questions.
- 20:52Speaker 1: And should you check to make sure that they're CPR
- 20:55Speaker 1: certified or at least somebody at all times is CPR
- 20:58Speaker 1: certified in the invention? And, you know, because we talk
- 21:00Speaker 1: about swimming and sometimes these after school activities are higher
- 21:03Speaker 1: risk than, say, just sitting in a classroom.
- 21:05Speaker 5: Yeah.
- 21:05Speaker 9: So you should have at least one CPR and first
- 21:10Speaker 9: aid certified staff member present in every room or for
- 21:14Speaker 9: every group activity. You want there to be adequate people
- 21:19Speaker 9: in case of an emergency situation.
- 21:21Speaker 1: And that's so important because a lot of times if
- 21:25Speaker 1: you're not prepared for it, these things come up unexpectedly
- 21:28Speaker 1: and they can potentially result in tragedy. We've seen this
- 21:31Speaker 1: in situations like what happened in Texas with the girls.
- 21:35Speaker 1: This was a summer program, but with the girls camp
- 21:37Speaker 1: where the river suddenly rose and just swept away all
- 21:41Speaker 1: of those campers. And tragically, there wasn't a whole lot
- 21:44Speaker 1: that could have been done other than the knowledge that
- 21:47Speaker 1: the camp does lie in a dangerous area and a floodplain.
- 21:49Speaker 1: And that was a consideration. So you have to be
- 21:52Speaker 1: careful when you're involved in something like that. You have
- 21:54Speaker 1: to plan ahead. You can't just deal with it as
- 21:57Speaker 1: it comes.
- 21:58Speaker 3: Right.
- 21:58Speaker 9: So looking specifically at the Camp Mystic tragedy, there were
- 22:03Speaker 9: so many campers that lost.
- 22:04Speaker 3: Their lives there.
- 22:05Speaker 1: Well, and I think the camp had some sort of
- 22:08Speaker 1: plan in place. In fact, I think every camp is
- 22:10Speaker 1: supposed to have emergency protocol plans in place for things
- 22:13Speaker 1: that are likely to happen. In the case of that camp,
- 22:16Speaker 1: it was located in a flood plain, so floods were common,
- 22:19Speaker 1: and they had a plan. I guess the flood came
- 22:21Speaker 1: upon them very suddenly. In the case of Alabama, we're
- 22:24Speaker 1: very prone to tornadoes, among other things, so there should
- 22:27Speaker 1: be tornado plans in place too. for every one of
- 22:29Speaker 1: these camps as part of their licensing. I guess you
- 22:33Speaker 1: have dealt with things like this in your practice, Lever
- 22:36Speaker 1: and Ecker, when it comes to negligence towards children. Can
- 22:40Speaker 1: you tell us a little bit more about what your
- 22:42Speaker 1: firm does?
- 22:42Speaker 3: Certainly.
- 22:43Speaker 9: My firm, we help families of people who have been injured,
- 22:46Speaker 9: and sometimes that includes children or youths that have been
- 22:50Speaker 9: injured at after-school programs or while participating in athletic events.
- 22:56Speaker 9: And being a part of this firm and doing the
- 22:59Speaker 9: work that we do, we see a lot of really
- 23:02Speaker 9: unfortunate incidences that happen due to the negligence of youth
- 23:08Speaker 9: programs that don't have adequate safety measures. So what I
- 23:12Speaker 9: always tell parents and guardians, again, is if your child
- 23:16Speaker 9: has been injured or compromised in some way, it doesn't
- 23:19Speaker 9: hurt to call an attorney and find out exactly what
- 23:23Speaker 9: your rights are and how you can best advocate for
- 23:25Speaker 9: your child.
- 23:27Speaker 1: Kate Henderson, thank you so much for joining us today
- 23:29Speaker 1: on Viewpoint, and these are all great things to remember
- 23:32Speaker 1: as we head back to school.
- 23:33Speaker 9: Yes, absolutely. Trust your gut, but always verify, and call
- 23:37Speaker 9: an attorney if you have any questions.
- 23:39Speaker 1: And finally today on Viewpoint Alabama, to round us out,
- 23:42Speaker 1: JT checks in with Paul Acey from Focus on the
- 23:45Speaker 1: Family to give us a few family-friendly suggestions as to
- 23:48Speaker 1: things that we can watch in the theaters or at home.
- 23:51Speaker 6: Good morning, sir. Welcome back in.
- 23:53Speaker 2: Good morning.
- 23:54Speaker 5: So happy to be here, JT.
- 23:56Speaker 6: All right.
- 23:56Speaker 4: I love it.
- 23:57Speaker 6: Please tell me this is going to be as good
- 23:58Speaker 6: as it needs to be. Coyote vs. Acme is hitting theaters.
- 24:03Speaker 7: So is this back to the old days of the coyote?
- 24:08Speaker 5: Well, yes, kind of.
- 24:12Speaker 8: Yeah.
- 24:12Speaker 5: So essentially what we have is Coyote has been chasing
- 24:15Speaker 5: the Roadrunner ever since, you know, 1949 is when he
- 24:19Speaker 5: started this chase. He's never caught him yet. He's kind
- 24:22Speaker 5: of bummed about it. And he realizes as the movie
- 24:25Speaker 5: goes on that one of the problems might be his
- 24:28Speaker 5: over-reliance on Acme products. You know, all the explosives that
- 24:33Speaker 5: he uses, all the dehydrated boulders he's tried on the Roadrunner,
- 24:39Speaker 5: all of these crazy, crazy gadgets, all of them sort
- 24:42Speaker 5: of backfire. And so he decides maybe it's time to
- 24:46Speaker 5: actually sue Acme. So he brings on this doubt on
- 24:51Speaker 5: his luck lawyer, and that's where the story picks up.
- 24:55Speaker 5: It had all the humor of the old cartoons. It
- 25:00Speaker 5: really embraced sort of the nostalgia of it all while
- 25:04Speaker 5: giving the movie a little bit of heart, believe it
- 25:07Speaker 5: or not, and updating it for a new audience.
- 25:10Speaker 7: Wow.
- 25:10Speaker 5: This isn't completely kid-friendly. There are a few anvils to
- 25:14Speaker 5: watch out for, but for the most part, I really
- 25:16Speaker 5: found this movie to be delightful.
- 25:18Speaker 7: Oh, I'm fired up about it. So kids can go
- 25:20Speaker 7: and everybody can enjoy this, the whole family.
- 25:22Speaker 5: Yeah, yeah. Again, parents would sure definitely check out our
- 25:26Speaker 5: review at PluggedIn just in case. But yeah, for the
- 25:28Speaker 5: most part, it's pretty navigable.
- 25:30Speaker 4: Love it, love it.
- 25:31Speaker 7: All right, let's talk about the Dog Stars, a big
- 25:33Speaker 7: player in theaters this weekend.
- 25:35Speaker 6: What's this all about?
- 25:36Speaker 5: Yeah, so this is not family friendly. Oh, okay. to
- 25:43Speaker 5: stay away from. This is directed by Ridley Scott, who
- 25:46Speaker 5: is really a top-notch director. He still has it. I
- 25:50Speaker 5: think he's like 140 now, but he is still making
- 25:53Speaker 5: some really strong movies. And this one has some very
- 25:57Speaker 5: interesting themes. It's a dystopian story. A lot of the
- 26:01Speaker 5: population of the world has died out after a huge
- 26:04Speaker 5: pandemic has swept through. And you have this tension between
- 26:09Speaker 5: good people who are just trying to make their way
- 26:11Speaker 5: for them and their families and really, really terrible people,
- 26:15Speaker 5: the scavengers who are trying to destroy everything and use
- 26:20Speaker 5: up everything for themselves. It is a harsh movie. It
- 26:24Speaker 5: is a strong movie. It is a thoughtful movie. And
- 26:27Speaker 5: so for adult audiences, there's plenty to think about as
- 26:31Speaker 5: you watch this film. But yeah, it has a lot
- 26:35Speaker 5: of really difficult content that people should be aware of.
- 26:38Speaker 4: Okay.
- 26:38Speaker 7: With that said, in this genre, is this one of
- 26:41Speaker 7: the better movies as far as these types of movies go?
- 26:44Speaker 5: You know, our reviewer really he walked away feeling really
- 26:48Speaker 5: strongly about it in terms of, yes, in terms of
- 26:51Speaker 5: the genre, in terms of, you know, these dystopian stories,
- 26:54Speaker 5: they often reflect bigger themes.
- 26:56Speaker 4: Right.
- 26:57Speaker 5: And the themes at the heart of this, what it
- 26:59Speaker 5: means to be good, what it means to survive, what
- 27:02Speaker 5: it means to take care of other people. These are
- 27:05Speaker 5: all really powerful themes within the movie. And so I
- 27:07Speaker 5: think that it does give a lot of food for thought.
- 27:10Speaker 6: All right, let's talk about some re-releases. This is kind
- 27:12Speaker 6: of interesting.
- 27:13Speaker 7: Both Harry Potter and the Philosopher's Stone and Terminator 2
- 27:16Speaker 7: Judgment Day are getting re-released.
- 27:18Speaker 6: What's going on?
- 27:19Speaker 5: Hollywood is leaning more and more on re-releases, I think.
- 27:21Speaker 5: They understand that there's an audience to see some of
- 27:24Speaker 5: these older movies back on the big screen. So these
- 27:26Speaker 5: are two huge players, obviously. Harry Potter and the Philosopher's Stone.
- 27:31Speaker 5: You can see all of Daniel Radcliffe and everybody else
- 27:35Speaker 5: when they were just little, tiny tots. It's a pretty fun,
- 27:41Speaker 5: strong movie that obviously launched a pretty significant franchise. And,
- 27:46Speaker 5: of course, Terminator 2, Judgment Day, back in the day,
- 27:49Speaker 5: was one of the highest-grossing films ever. This stars Arnold Schwarzenegger,
- 27:54Speaker 5: this time as a good guy coming back from the
- 27:57Speaker 5: future to defend humanity in the form of a 12-year-old boy. Uh,
- 28:03Speaker 5: so if you're familiar with those and you've always wanted
- 28:06Speaker 5: to see them on the big screen, but just didn't
- 28:08Speaker 5: make it, or if you were just too young to
- 28:10Speaker 5: see them at the time, uh, this is your opportunity.
- 28:13Speaker 9: All right.
- 28:13Speaker 7: Also in the streaming world this weekend, the whisper man,
- 28:16Speaker 7: this is a thriller and I love thrillers and I
- 28:19Speaker 7: like Robert De Niro, the actor. I don't like Robert
- 28:22Speaker 7: De Niro, the activist, crazy lefty, but, uh, you know, I,
- 28:26Speaker 7: I'm going to put that aside because I do like
- 28:28Speaker 7: these kinds of movies.
- 28:29Speaker 6: This will be on Netflix. What's the whisper man all about?
- 28:32Speaker 5: The Whisper Man involves– it essentially is about this widowed
- 28:37Speaker 5: crime story writer whose boy is abducted. His eight-year-old boy
- 28:42Speaker 5: is abducted. He has to sort of bring in his
- 28:46Speaker 5: estranged dad, who's played by De Niro. He plays this
- 28:50Speaker 5: retired detective. And so they start looking for him, and
- 28:53Speaker 5: they realize that there's a connection to an old serial
- 28:56Speaker 5: killer known as the Whisper Man. This, not only does
- 29:00Speaker 5: it have Robert De Niro, but it has Adam Scott.
- 29:04Speaker 5: It has Michael Keaton in a role. It has Michelle Olsen.
- 29:07Speaker 5: So this is a really strong cast for this Netflix movie.
- 29:11Speaker 5: It's rated R. It's going to have some harsh content.
- 29:14Speaker 5: We haven't seen it yet. But, man, you can't argue
- 29:17Speaker 5: with the cast, right? I think that the cast alone
- 29:20Speaker 5: makes you curious to see what this is going to
- 29:22Speaker 5: be all about.
- 29:23Speaker 7: Yeah, I've always been a Michael Keaton fan. He's a
- 29:24Speaker 7: fellow Pittsburgher. So, yeah, he's been solid my entire life
- 29:28Speaker 7: watching his movies.
- 29:29Speaker 4: Love him.
- 29:29Speaker 6: So this does look pretty good.
- 29:30Speaker 7: Paul, I got to tell you, it looks like there's
- 29:32Speaker 7: a little something for everybody in theaters or streaming this weekend.
- 29:35Speaker 5: You got it. It's a little bit of a grab bag,
- 29:37Speaker 5: but a good one, I think.
- 29:38Speaker 8: You've been listening to Viewpoint Alabama, a public affairs program
- 29:42Speaker 8: from the Alabama Radio Network. The opinions expressed on Viewpoint
- 29:45Speaker 8: Alabama are not necessarily those of the staff, management, or
- 29:48Speaker 8: advertisers of this station.